Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori
Abstract Background Clarithromycin-resistance is becoming a global health concern in the treatment of Helicobacter pylori (H. pylori). The mutant prevention concentration (MPC) represent the propensities of antimicrobial agents to select resistant mutants. The concentration range between the minimum...
Main Authors: | Zi-Han Feng, Ling Fan, Jing Yang, Xing-Yue Huo, Yan Guo, Yi Zhang, Chun-Hui Lan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | BMC Microbiology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12866-019-1558-8 |
Similar Items
-
Identification of the Prevalence of Resistance to Clarithromycin in Helicobacter Pylori Isolated from Gastric Biopsy via PCR Method
by: A Ghorbani ranjbary, et al.
Published: (2015-05-01) -
Phenotype and Molecular Detection of Clarithromycin and Levofloxacin Resistance in Helicobacter pylori Clinical Isolates in Beijing
by: Lok CH, et al.
Published: (2020-07-01) -
RESISTANCE TO AMOXICILLIN, CLARITHROMYCIN AND CIPROFLOXACIN OF Helicobacter pylori ISOLATED FROM SOUTHERN BRAZIL PATIENTS
by: Simone Ulrich Picoli, et al.
Published: (2014-06-01) -
High frequency of A2143G mutation in clarithromycin-resistant Helicobacter pylori isolates recovered from dyspeptic patients in Iran
by: Amin T Abadi, et al.
Published: (2011-01-01) -
Resistance pattern of Helicobacter pylori strains to clarithromycin, metronidazole, and amoxicillin in Isfahan, Iran
by: Farzad Khademi, et al.
Published: (2013-01-01)